Cost Conversations About Anticoagulation Between Patients With Atrial Fibrillation and Their Clinicians: A Secondary Analysis of a Randomized Clinical Trial.

ABSTRACT:

Importance

How patients with atrial fibrillation (AF) and their clinicians consider cost in forming care plans remains unknown.

Objective

To identify factors that inform conversations regarding costs of anticoagulants for treatment of AF between patients and clinicians and outcomes associated with these conversations.

Design, setting, and participants

This cohort study of recorded encounters and participant surveys at 5 US medical centers (including academic, community, and safety-net centers) from the SDM4AFib randomized trial compared standard AF care with and without use of a shared decision-making (SDM) tool. Included patients were considering anticoagulation treatment and were recruited by their clinicians between January 30, 2017, and June 27, 2019. Data were an

SUBMITTER: Kamath CC 

PROVIDER: S-EPMC8278261 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature